XML 47 R36.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue from Contracts with Customers (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 9 Months Ended
Sep. 29, 2023
Sep. 30, 2022
Sep. 30, 2022
Jun. 16, 2022
Sep. 29, 2023
Dec. 30, 2022
Dec. 31, 2021
Disaggregation of Revenue [Line Items]              
Revenue Reserves $ 256.8 $ 258.8 $ 258.8 $ 276.9 $ 256.8 $ 294.0 $ 272.8
Revenue Reserve Provision   459.8   715.7 1,195.1    
Revenue Reserve Payments or Credits   (477.9)   (711.6) (1,232.3)    
Net sales 497.0 $ 550.4 $ 465.4 $ 874.6 1,396.6    
Accrued Medicaid 57.2       57.2 89.3  
Accrued rebates $ 35.9       $ 35.9 55.3  
Transferred at Point in Time [Member]              
Disaggregation of Revenue [Line Items]              
Revenue 85.10% 82.60% 82.40% 80.80% 83.10%    
Transferred over Time [Member]              
Disaggregation of Revenue [Line Items]              
Revenue 14.90% 17.40% 17.60% 19.20% 16.90%    
Royalty [Member]              
Disaggregation of Revenue [Line Items]              
Net sales $ 0.2 $ 21.2 $ 18.2 $ 34.9 $ 4.0    
Rebates and Chargebacks [Member]              
Disaggregation of Revenue [Line Items]              
Revenue Reserves [1] 230.7 218.1 218.1 250.6 230.7 265.3 241.8
Revenue Reserve Provision [1]   429.9   693.4 1,150.5    
Revenue Reserve Payments or Credits [1]   (462.4)   (684.6) (1,185.1)    
Allowance for Sales Returns [Member]              
Disaggregation of Revenue [Line Items]              
Revenue Reserves 13.3 17.4 17.4 18.6 13.3 16.0 21.5
Revenue Reserve Provision   3.1   5.2 8.5    
Revenue Reserve Payments or Credits   (4.3)   (8.1) (11.2)    
Other Sales Deductions [Member]              
Disaggregation of Revenue [Line Items]              
Revenue Reserves $ 12.8 23.3 $ 23.3 7.7 12.8 $ 12.7 $ 9.5
Revenue Reserve Provision   26.8   17.1 36.1    
Revenue Reserve Payments or Credits   $ (11.2)   $ (18.9) $ (36.0)    
[1] Includes $57.2 million and $89.3 million of accrued Medicaid and $35.9 million and $55.3 million of accrued rebates as of September 29, 2023 (Successor) and December 30, 2022 (Successor), respectively, included within accrued and other current liabilities in the unaudited condensed consolidated balance sheets.